Hint mode is switched on Switch off
For swift navigation between sections

Amgen
LEI 62QBXGPJ34PQ72Z12S66, SWIFT AGGNUS62XXX

Organization name
Amgen, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
60,442 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    62QBXGPJ34PQ72Z12S66
  • SWIFT
    AGGNUS62XXX
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • ICB
    4,500 Health Care
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0000318154
  • EIN
    95-3540776
Registration is required to get access.